课题基金 / 基金详情

The induction of donor-specific transplantation tolerance in pancreas transplantation combined with spleen in rat

The induction of donor-specific transplantation tolerance in pancreas transplantation combined with spleen in rat
大鼠胰脏联合移植诱导供者特异性移植耐受
批准号:
16591262
负责人:
SUGITANI Atsushi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

SUGITANI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
目的:目的:探讨脾脏和调节性T细胞在胰腺移植中的作用。方法:采用链脲佐菌素(STZ)诱导大鼠糖尿病模型,采用改良Lee法进行脾和/或胰十二指肠移植(S/PTx或PTx)。比较了同系移植物(Lew至Lew)、同种异体移植物(DA至Lew)和同种异体移植物加他克莫司诱导(1 mg/kg/天,持续4d)组的移植物存活率。采用流式细胞术和RT-PCR分别检测外周血(PB)、受体脾(RS)和供体脾(DS)中CD 25 + CD 4 + T细胞比例和Foxp 3表达。第7天取RS、DS和移植胰腺组织行组织学检查。结果:同系移植的S/PTx(n=4)和PTx(n=4)均存活100天以上。S/PTx(n=6)和PTx(n=6)在未加他克莫司的情况下分别于12.3±2.7d和11.7±2.9d出现排斥反应。S/PTx组(n=6)生存时间为22.8±7.9d,PTx组(n=6)生存时间为13.5±3.7d(p=0.0069)。排斥反应S/PTx移植物(n=5)PB、RS和DS中以CD 25 + CD 4 +T细胞为主,2)供者来源的CD 25 + CD 4 +T细胞在7天后消失。存活的S/PTx移植物(n=5)显示:1)供体CD 25 + CD 4 +T细胞在PB、RS和DS中保留超过7天,2)Foxp 3在RS和DS中的表达率在第7天与排斥移植物相比(p=0.028)。结论:联合脾移植和短疗程钙调磷酸酶抑制剂可延长移植胰腺的存活时间。供、受者脾脏中同时存在的供者源性调节性T细胞(Foxp 3和CD 25/4细胞)可导致微嵌合和延长生存期。
英文摘要
Aim : To investigate the role of spleen and regulatory T cell for pancreas transplantation.Method : After induction of diabetes mellitus by streptozotocin, spleen and/or pancreaticoduodenal transplantation (S/PTx or PTx) into the peritoneal cavity was performed using a modification of Lee's method. Graft survival was compared in isograft (Lew to Lew), allograft (DA to Lew) and allograft with tacrolimus induction (1mg/kg/day for 4days) groups. The rate of CD25+CD4+ T cell and the Foxp3 expression in peripheral blood (PB), recipient spleen (RS) and donor spleen (DS) were examined using Flowcytometry and RT-PCR, respectively. The specimen was obtained from RS, DS, and graft pancreas for histological examination on day7.Results : Isotransplanted S/PTx (n=4) and PTx (n=4) were both survived longer than 100days. Both allotransplanted S/PTx (n=6) and PTx (n=6) without tacrolimus rejected the graft on 12.3±2.7d, 11.7±2.9d, respectively. S/PTx (n=6) with tacrolimus survived for 22.8±7.9d, and PTx (n=6) with tacrolimus survived for 13.5±3.7d (p=0.0069). Rejected S/PTx grafts (n=5) showed that 1)CD25+CD4+T cells were dominant in PB, RS and DS, 2) Donor derived CD25+CD4+T cells disappeared after 7days. Survived S/PTx grafts (n=5) showed that 1)donor CD25+CD4+T cells remained in PB, RS and DS over 7days, 2)the rate of Foxp3 expression was in both RS and DS on day7 compared with Rejected graft (p=0.028). There were more lymphocyte infiltration and reduction in white pulp in RS and DS.Conclusion : The pancreas graft survived longer by combined spleen transplantation and a short course of calcineurin inhibitor. Donor derived regulatory T cells (Foxp3 and CD25/4 cells) existing in both recipient and donor spleen would lead micro-chimerism and prolonged survival.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
ラット膵臓移植モデルにおける脾臓を用いた免疫寛容誘導の可能性
在大鼠胰腺移植模型中使用脾脏诱导免疫耐受的可能性
DOI: --
发表时间: 2005
期刊: 日本移植学会 40
影响因子: --
作者: [吉田淳一, 田中三津子, 杉谷篤, 北田秀久, 大田守仁, 田中雅夫]
通讯作者: 田中雅夫
Long-Term Results of Tacrolimus Therapy for Renal Transplantation in Patients With Diabetic Nephropathy in Japan (for the Japanese Tacrolimus Study)
他克莫司治疗日本糖尿病肾病患者肾移植的长期结果(针对日本他克莫司研究)
DOI: --
发表时间: 2005
期刊: Transplantation Proceedings 37
影响因子: --
作者: [A.Sugitani, M.Tanaka, S.Takahara, K.Uchida, H.Yoshimura, K.Takahashi, H.Toma, S.Oshima, T.Sonoda]
通讯作者: T.Sonoda
DOI: --
发表时间: 2005
期刊: Transplantation Proceedings 37
影响因子: --
作者: [A.Sugitani, M.Tanaka, S.Takahara, K.Uchida, H.Yoshimura, K.Takahashi, H.Toma, S.Oshima, T.Sonoda for the Japanese Tacrolimus Study]
通讯作者: T.Sonoda for the Japanese Tacrolimus Study
DOI: --
发表时间: 2005
期刊: The Japan Society for Transplantation 40
影响因子: --
作者: [J.Yoshida, M.Tanaka, A.Sugitani, H.Kitada, M.Ota, M.Tanaka]
通讯作者: M.Tanaka
共 15 条
    The clinical application of split pancreas transplantation for the shortage of donors declared brain dead.
    • 批准号:
      10671122
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1998
    • 负责人:
      SUGITANI Atsushi
    • 依托单位:
    海外基金